Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Progesterone Signaling for Breast Cancer Prevention in BRCA1 Carriers: a Pilot Study

NCT05062174 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05062174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05062174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Progesterone Signaling for Breast Cancer Prevention in BRCA1 Carriers: a Pilot Study
Lead sponsor
Indiana University
Phase
Observational
Overall status
Withdrawn
Start date
November 1, 2021
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, high-grade serous ovarian cancer, tnbc - triple-negative breast cancer